SK279399B6 - Cyklický peptid, spôsob jeho výroby a farmaceutick - Google Patents

Cyklický peptid, spôsob jeho výroby a farmaceutick Download PDF

Info

Publication number
SK279399B6
SK279399B6 SK3086-92A SK308692A SK279399B6 SK 279399 B6 SK279399 B6 SK 279399B6 SK 308692 A SK308692 A SK 308692A SK 279399 B6 SK279399 B6 SK 279399B6
Authority
SK
Slovakia
Prior art keywords
lys
asp
ala
seq
boc
Prior art date
Application number
SK3086-92A
Other languages
English (en)
Slovak (sk)
Other versions
SK308692A3 (en
Inventor
David R. Bolin
Margaret O'donnell
Original Assignee
F. Hoffmann-La Roche Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F. Hoffmann-La Roche Ag filed Critical F. Hoffmann-La Roche Ag
Publication of SK308692A3 publication Critical patent/SK308692A3/sk
Publication of SK279399B6 publication Critical patent/SK279399B6/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/57563—Vasoactive intestinal peptide [VIP]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/17—Vasoactive intestinal peptides; related peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/27—Cyclic peptide or cyclic protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SK3086-92A 1991-10-11 1992-10-09 Cyklický peptid, spôsob jeho výroby a farmaceutick SK279399B6 (sk)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US77374791A 1991-10-11 1991-10-11

Publications (2)

Publication Number Publication Date
SK308692A3 SK308692A3 (en) 1995-03-08
SK279399B6 true SK279399B6 (sk) 1998-11-04

Family

ID=25099195

Family Applications (1)

Application Number Title Priority Date Filing Date
SK3086-92A SK279399B6 (sk) 1991-10-11 1992-10-09 Cyklický peptid, spôsob jeho výroby a farmaceutick

Country Status (26)

Country Link
US (1) US5677419A (zh)
EP (1) EP0536741B1 (zh)
JP (1) JP2515473B2 (zh)
KR (1) KR970001580B1 (zh)
CN (3) CN1034943C (zh)
AT (1) ATE132165T1 (zh)
AU (1) AU656230B2 (zh)
BG (1) BG61125B2 (zh)
BR (1) BR9203959A (zh)
CA (1) CA2080272C (zh)
CZ (1) CZ281818B6 (zh)
DE (1) DE69207138T2 (zh)
DK (1) DK0536741T3 (zh)
ES (1) ES2082317T3 (zh)
FI (2) FI111646B (zh)
GR (1) GR3019326T3 (zh)
HU (2) HUT62606A (zh)
IL (3) IL117252A (zh)
MX (1) MX9205822A (zh)
NO (3) NO304523B1 (zh)
NZ (1) NZ244644A (zh)
RU (1) RU2095368C1 (zh)
SK (1) SK279399B6 (zh)
TW (1) TW305846B (zh)
UY (2) UY23488A1 (zh)
ZA (1) ZA927724B (zh)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6872803B1 (en) 1993-09-21 2005-03-29 Kyowa Hakko Kogyo Co., Ltd. Peptides
HUP9900961A3 (en) * 1996-02-09 2001-06-28 Hoffmann La Roche Synthesis of vip analog
EP0975374B1 (en) * 1996-07-12 2007-12-05 Immunomedics, Inc. Radiometal-binding peptide analogues
WO1998002453A2 (en) * 1996-07-15 1998-01-22 Universite Libre De Bruxelles Peptidic ligands having a higher selectivity for the vip1 receptor than for the vip2 receptor
US6972319B1 (en) 1999-09-28 2005-12-06 Bayer Pharmaceuticals Corporation Pituitary adenylate cyclase activating peptide (PACAP)receptor 3 (R3) agonists and their pharmacological methods of use
PE20010612A1 (es) * 1999-09-28 2001-07-12 Bayer Corp Agonistas del receptor 3 (r3) del peptido activador de la adenilato ciclasa de la pituitaria y su uso farmacologico
DE60033697D1 (de) 2000-02-18 2007-04-12 Dabur Res Foundation Sahibabad Radiomarkierte vip-analoge zur diagnose und therapie
AU2000265051A1 (en) * 2000-02-18 2001-08-27 Dabur Research Foundation Vasoactive intestinal peptide analogs
US6828304B1 (en) 2000-07-31 2004-12-07 Dabur Research Foundation Peptides for treatment of cancer
US7507714B2 (en) * 2000-09-27 2009-03-24 Bayer Corporation Pituitary adenylate cyclase activating peptide (PACAP) receptor 3 (R3) agonists and their pharmacological methods of use
JP2004514697A (ja) 2000-11-28 2004-05-20 モンドバイオテック・ソシエテ・アノニム 肺及び細動脈高血圧症治療用の血管作動性腸管ペプチドの生物学的活性をもつ化合物
DE60326723D1 (de) 2002-06-10 2009-04-30 Mondobiotech Licensing Out Ag Verwendung von zusammensetzungen mit der biologischen aktivität der vasoaktiven intestinalen peptide zur behandlung von sarcoidose
CA2554475A1 (en) * 2004-01-27 2005-08-11 Bayer Pharmaceuticals Corporation Pituitary adenylate cyclase activating peptide (pacap) receptor (vpac2) agonists and their pharmacological methods of use
US20080085860A1 (en) * 2004-08-18 2008-04-10 Eli Lilly And Company Selective Vpac2 Receptor Peptide Agonists
EP1781695A1 (en) * 2004-08-18 2007-05-09 Eli Lilly And Company Selective vpac2 receptor peptide agonists
CA2638733A1 (en) * 2006-02-28 2007-09-07 Eli Lilly And Company Selective vpac2 receptor peptide agonists
WO2008003612A2 (en) * 2006-07-06 2008-01-10 F. Hoffmann-La Roche Ag Analogs of vasoactive intestinal peptide
CN101906144B (zh) * 2009-06-03 2013-06-19 首都医科大学 一根Arg-Gly-Asp-Val链通过Asp与两根脂肪醇链的偶联物、它们的合成及在医学中的应用
AU2010282250B2 (en) 2009-08-14 2015-11-12 Immunoforge Co., Ltd. Modified Vasoactive Intestinal Peptides
CA2797033C (en) 2010-04-22 2021-10-19 Longevity Biotech, Inc. Highly active polypeptides and methods of making and using the same
CA2873553C (en) 2011-06-06 2020-01-28 Phasebio Pharmaceuticals, Inc. Use of modified vasoactive intestinal peptides in the treatment of hypertension
US9789164B2 (en) 2013-03-15 2017-10-17 Longevity Biotech, Inc. Peptides comprising non-natural amino acids and methods of making and using the same
GB201421647D0 (en) * 2014-12-05 2015-01-21 Amcure Gmbh And Ruprecht-Karls-Universitat And Karlsruher Institut F�R Technologie CD44v6-derived cyclic peptides for treating cancers and angiogenesis related diseases
EP3256151B1 (en) 2015-02-09 2020-08-05 Phasebio Pharmaceuticals, Inc. Methods and compositions for treating muscle disease and disorders
BR112019006301A2 (pt) 2016-09-30 2019-07-30 Fujifilm Corp peptídeo cíclico, suporte de cromatografia de afinidade, anticorpo marcado, conjugado anticorpo - fármaco, e preparação farmacêutica

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8427651D0 (en) * 1984-11-01 1984-12-05 Beecham Group Plc Compounds
US4835252A (en) * 1987-02-26 1989-05-30 The Salk Institute Biotechnology/Industrial Associates, Inc. Vasoactive intestinal peptide analogs
GB8729802D0 (en) * 1987-12-22 1988-02-03 Beecham Group Plc Novel compounds
US5084442A (en) * 1988-09-06 1992-01-28 Hoffmann-La Roche Inc. Cyclic growth hormone releasing factor analogs and method for the manufacture thereof
US5141924A (en) * 1989-06-30 1992-08-25 Hoffmann-La Roche, Inc. Synthetic vasoactive intestinal peptide analogs

Also Published As

Publication number Publication date
EP0536741A3 (zh) 1994-04-06
CN1152579A (zh) 1997-06-25
NO980377L (no) 1993-04-13
CN1153785A (zh) 1997-07-09
KR970001580B1 (ko) 1997-02-11
FI924580A (fi) 1993-04-12
CN1072415A (zh) 1993-05-26
FI924580A0 (fi) 1992-10-09
NO304523B1 (no) 1999-01-04
CZ308692A3 (en) 1993-08-11
CN1198841C (zh) 2005-04-27
UY25084A1 (es) 1998-12-21
CA2080272C (en) 2002-09-17
TW305846B (zh) 1997-05-21
EP0536741B1 (en) 1995-12-27
AU2622892A (en) 1993-04-22
JP2515473B2 (ja) 1996-07-10
UY23488A1 (es) 1993-04-20
FI111646B (fi) 2003-08-29
SK308692A3 (en) 1995-03-08
NO975023D0 (no) 1997-10-31
NO923929L (no) 1993-04-13
BR9203959A (pt) 1993-04-27
NZ244644A (en) 1995-04-27
AU656230B2 (en) 1995-01-27
ATE132165T1 (de) 1996-01-15
HUT62606A (en) 1993-05-28
NO980377D0 (no) 1998-01-28
EP0536741A2 (en) 1993-04-14
IL117252A (en) 1999-11-30
MX9205822A (es) 1993-06-01
DE69207138T2 (de) 1996-06-13
CA2080272A1 (en) 1993-04-12
FI20002041A (fi) 2000-09-15
HU211534A9 (en) 1995-12-28
JPH05213996A (ja) 1993-08-24
CN1225473C (zh) 2005-11-02
ES2082317T3 (es) 1996-03-16
DK0536741T3 (da) 1996-04-22
CN1034943C (zh) 1997-05-21
GR3019326T3 (en) 1996-06-30
RU2095368C1 (ru) 1997-11-10
IL117252A0 (en) 1996-06-18
NO975023L (no) 1993-04-13
KR930007972A (ko) 1993-05-20
HU9203194D0 (en) 1992-12-28
ZA927724B (en) 1994-04-07
CZ281818B6 (cs) 1997-02-12
IL103396A0 (en) 1993-03-15
US5677419A (en) 1997-10-14
DE69207138D1 (de) 1996-02-08
IL103396A (en) 1997-11-20
NO923929D0 (no) 1992-10-09
BG61125B2 (bg) 1996-11-29

Similar Documents

Publication Publication Date Title
SK279399B6 (sk) Cyklický peptid, spôsob jeho výroby a farmaceutick
US4605641A (en) Synthetic vasoactive intestinal peptide analogs
FI88402B (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara grf-analoger
US5583108A (en) Vasonatrin peptide and analogs thereof
US5106834A (en) Linear free-sulfhydryl-containing oligopeptide derivatives as antihypertensive agents
SK88893A3 (en) Novel amylin antagonist peptides and uses therefor
WO1990003980A1 (en) Therapeutic peptides
US4734400A (en) Synthetic vasoactive intestinal peptide analogs
AU6751290A (en) Synthetic calcitonin peptides
US5141924A (en) Synthetic vasoactive intestinal peptide analogs
EP0363589A2 (en) Somatostatin analogues
KR100629013B1 (ko) Ｉｇｆ-ⅰ 및 -ⅱ를 억제하는 ｇｈ-ｒｈ의 길항 유사체
US5234907A (en) Synthetic vasoactive intestinal peptide analogs
AU8237187A (en) Derivatives of atrial natriuretic peptides
WO1989010935A1 (en) Atrial peptide derivatives
IE53488B1 (en) Crf and analogues
EP0307860B1 (en) Cyclic GRF-analogs
FI111647B (fi) Menetelmä terapeuttisesti käyttökelpoisten syklisten peptidien valmistamiseksi
US5013721A (en) Anorexigenic and hypotensive peptides
US5502164A (en) Peptide compounds having therapeutic activity